Are you Dr. Forero?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1000 S Coulter St
Suite 100
Amarillo, TX 79106Phone+1 806-358-8654Fax+1 806-356-8687
Summary
- Dr. Leonardo Forero, MD is an oncologist in Amarillo, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with Northwest Texas Healthcare System, BSA Hospital, LLC, and Thomas E. Creek Department of Veterans Affairs Medical Center.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2000 - 2003
University of Texas Southwestern Medical Center/St Paul Medical CenterResidency, Internal Medicine, 1998 - 2000- University of Texas Southwestern Medical CenterInternship, Internal Medicine, 1997 - 1998
Colegio Mayor de Nuestra Señora del RosarioClass of 1992
Certifications & Licensure
TX State Medical License 2004 - 2026- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
- A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Start of enrollment: 2014 Apr 09
Publications & Presentations
PubMed
- 28 citationsA phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanomaMonica M. Mita, Eric K. Rowinsky, Leonardo Forero, S. Gail Eckhart, Elzbieta Izbicka
Cancer Chemotherapy and Pharmacology. 2007-02-01 - 21 citationsCantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic studyJordi Rodon, Mitchell Garrison, Lisa A. Hammond, Johann S. de Bono, Lon Smith
Cancer Chemotherapy and Pharmacology. 2008-02-27 - 8 citationsPhase I and Pharmacokinetic Study of Sequences of the Rebeccamycin Analogue NSC 655649 and Cisplatin in Patients with Advanced Solid TumorsA. Ricart, Lisa A. Hammond, John G. Kuhn, Chris H. Takimoto, Andrew Goetz
Clinical Cancer Research. 2005-12-15
Press Mentions
Oncologist Teams with Local Food Services to Offer Patients Healthy ChoicesNovember 17th, 2021
